Skip to main content
logo
Merck & Co., Inc. (MRK)
NYSE: MRK · Real-Time Price · USD
147.76
-0.59 (-0.40%)
At close: Aug 31, 2026, 4:00 PM EDT
148.32
+0.56 (0.38%)
After-hours: Aug 31, 2026, 7:58 PM EDT

Merck & Co. Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Revenue
16,60716,28616,40017,27615,80615,52915,62416,65716,11215,77514,63015,96215,03514,48713,83014,95914,59315,90113,52113,154
Revenue Growth
5.07%4.88%4.97%3.72%-1.90%-1.56%6.79%4.35%7.16%8.89%5.79%6.71%3.03%-8.89%2.28%13.72%27.99%49.63%23.50%20.36%
Gross Profit
12,47912,41112,10513,53112,41412,14611,91712,76912,43312,35110,83511,73111,04310,5909,98711,07910,44410,5679,4349,752
Operating Income
-406,2875,3757,0495,9236,2218,0974,3646,3846,699-6546,0835,8825,1434,3295,1345,2105,8173,6005,043
Net Income
-1,335-4,2402,9635,7854,4275,0793,7433,1575,4554,762-1,2264,745-5,9752,8213,0173,2483,9444,3103,7584,567
Earnings Per Share
-0.54-1.721.192.321.762.011.481.242.141.87-0.481.86-2.351.111.181.281.551.701.481.80
EPS Growth
---19.28%86.99%-17.76%7.49%--33.33%-68.47%-45.31%--34.71%-20.00%-28.89%154.12%35.91%-54.78%

Revenue by Segment
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Keytruda/Keytruda Qlex
8,3668,0348,3728,1477,9567,2057,8367,4297,2706,9476,6086,3386,2715,7955,4505,4265,2524,8094,5774,534
Gardasil/Gardasil 9
1,1691,0691,0311,7491,1261,3271,5502,3062,4782,2491,8712,5852,4581,9721,4702,2941,6741,4601,5281,993
Januvia/Janumet
4295745016246237964874826296707878358648809131,1331,2331,2331,3931,339
ProQuad/M-M-R II/Varivax
592538619684609539594703617570545713582528526668578470509661
Bridion
497472499439461441449420455440429424502487441423426395436369
Lynparza - Alliance
365341389379370312365337317292315299310275292284275266268246
Winrevair
58852546736033628020014970-----------
Lenvima - Alliance
283256272258265258255251249255226260242232216202231227206188
Animal Health
1,7751,7911,5051,6151,6461,5881,3971,4871,4821,5111,2781,4001,4561,4911,2301,3711,4671,4821,2611,417
Other Product
721465250110303185227222258211299122275420625370312221241
Revenue (Total)
16,60716,28616,40017,27615,80615,52915,62416,65716,11215,77514,63015,96215,03514,48713,83014,95914,59315,90113,52113,154

Cash & Debt
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Cash & Investments
7,1415,70214,56518,2148,6229,22813,68914,59311,3545,6197,0938,7736,37810,38713,19211,24810,1298,9328,09610,042
Total Debt
53,91149,11750,53441,37435,40234,84438,27038,13137,78834,21936,26834,86736,91130,74731,98530,41831,66331,79434,63126,441
Net Cash (Debt)
-46,770-43,415-35,969-23,160-26,780-25,616-24,581-23,538-26,434-28,600-29,175-26,094-30,533-20,360-18,793-19,170-21,534-22,862-26,535-16,399
Net Cash Growth
--------------------
Net Cash Per Share
-18.94-17.56-14.46-9.27-10.66-10.12-9.69-9.26-10.39-11.24-11.52-10.25-12.03-7.98-7.38-7.54-8.48-9.01-10.47-6.47

Cash Flow & CapEx
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Operating Cash Flow
5,3703,9182,8577,8223,2932,5003,4509,2915,6373,0902467,7173,7041,3394,4305,6024,3024,7615,0314,797
Capital Expenditures
-893-991-1,033-987-764-1,328-937-783-791-861-989-902-965-1,007-1,149-1,126-1,129-984-1,208-1,172
Free Cash Flow
4,4772,9271,8246,8352,5291,1722,5138,5084,8462,229-7436,8152,7393323,2814,4763,1733,7773,8233,625
Free Cash Flow Growth
77.03%149.74%-27.42%-19.66%-47.81%-47.42%-24.84%76.93%571.39%-52.26%-13.68%-91.21%-14.18%23.48%92.89%564.97%49.16%-

Margins
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Gross Margin
75.14%76.21%73.81%78.32%78.54%78.22%76.27%76.66%77.17%78.30%74.06%73.49%73.45%73.10%72.21%74.06%71.57%66.45%69.77%74.14%
Operating Margin
-0.24%38.60%32.77%40.80%37.47%40.06%51.82%26.20%39.62%42.47%-4.47%38.11%39.12%35.50%31.30%34.32%35.70%36.58%26.63%38.34%
Pretax Margin
-4.11%-21.70%20.85%39.04%31.63%38.01%26.69%24.55%37.28%35.94%-13.98%35.21%-35.48%25.20%25.40%23.95%30.75%30.57%28.91%40.03%
Profit Margin
-8.04%-26.04%18.07%33.49%28.01%32.71%23.96%18.95%33.86%30.19%-8.38%29.73%-39.74%19.47%21.82%21.71%27.03%27.11%27.79%34.72%
FCF Margin
26.96%17.97%11.12%39.56%16.00%7.55%16.08%51.08%30.08%14.13%-5.08%42.70%18.22%2.29%23.72%29.92%21.74%23.75%28.27%27.56%

Dividends
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Dividend Per Share
0.8500.8500.8100.8100.8100.8100.7700.7700.7700.7700.7300.7300.7300.7300.6900.6900.6900.6900.6500.650
Dividend Per Share Growth
4.94%4.94%5.20%5.20%5.20%5.20%5.48%5.48%5.48%5.48%5.80%5.80%5.80%5.80%6.15%6.15%6.15%6.15%6.56%6.56%
Dividend Yield
2.58%2.75%3.12%3.90%4.13%3.63%3.26%2.84%2.59%2.41%2.90%3.05%2.70%2.91%2.77%3.54%3.32%3.66%3.89%3.95%

Valuation
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
PE Ratio
--14.3111.0112.1213.0114.7023.7022.83144.92-56.69-20.7319.3814.3013.9114.6314.8426.42
Forward PE
20.9223.4712.189.168.8310.0011.0513.3113.9715.3517.4713.3315.7115.2415.4512.5113.1511.2310.9712.56
P/FCF Ratio
19.7621.0721.1416.0713.5013.3113.9119.4023.8530.27-19.8427.0423.9819.1314.3116.0116.1120.0422.63
PS Ratio
4.774.524.023.263.133.553.924.565.025.444.604.405.024.674.753.704.033.843.984.12